Proteases inhibition
What is Proteases inhibition?
Protease inhibition testing for barrier function measures whether an ingredient alters enzymes involved in epidermal protein turnover and shedding. Kallikrein-focused assays and skin-model follow-up help determine whether inhibition supports balanced desquamation rather than simply suppressing all proteolysis.
Why do you need this service?
Barrier-focused protease assays investigate enzymes involved in epidermal processing and shedding. Biochemical inhibition and skin-model follow-up help distinguish balanced desquamation from excessive suppression of normal turnover.
Be the first company on this service page
No published company profiles are linked to Proteases inhibition or its more specific services yet. Explore the service categories or add an explicitly supported capability to your company profile.
Protease inhibition and epidermal barrier regulation
Proteases participate in normal epidermal processing and corneodesmosome breakdown. Excessive activity can impair cohesion, but excessive inhibition can also disturb shedding. Barrier-focused testing therefore examines the specific enzyme and biological context.
Enzyme assays
Purified-enzyme assays use defined substrates to measure residual activity after exposure to a test material. Relevant targets may include KLK5, KLK7, KLK14, or selected cathepsins. Matrix metalloproteinase assays address additional matrix-remodeling questions rather than serving as direct substitutes for epidermal protease testing.
- Concentration-response curves and IC50 estimates where justified
- Reference inhibitors and vehicle controls
- Checks for substrate or detection interference
- Assay conditions, including pH, matched to the question
Skin-model interpretation
Cell or tissue studies can investigate whether enzyme inhibition changes corneodesmosomal protein turnover, cohesion, or barrier properties. Collagen and elastin degradation are not the primary endpoints for this epidermal barrier service.
Reports should distinguish biochemical inhibition from functional barrier protection. Neither an IC50 value nor a viability check establishes a safe finished-product concentration or proves barrier repair during consumer use.
Testing epidermal protease activity
Defined substrates and purified enzymes can compare effects on targets such as KLK5, KLK7, KLK14 or selected cathepsins. Concentration-response curves and IC50 estimates need appropriate reference inhibitors and controls for detection interference and pH.
Follow-up in skin models can investigate corneodesmosomal turnover, cohesion or permeability. Collagen and elastin degradation are matrix-remodelling questions, not direct substitutes for these epidermal barrier endpoints.
Inhibition is not inherently beneficial: excessive suppression can disturb normal shedding. Reports should separate biochemical potency from functional barrier effects and avoid treating an assay concentration as a safe finished-product use level.
Investigate barrier and hydration mechanisms through epidermal lipids, junction proteins, differentiation and water-handling responses in skin models. Explore another Barrier & Hydration Mechanisms page on cosmetic-labs.com.